Chemotherapy-Induced Peripheral Neuropathic Pain and the Impact on the Quality of Life

Authors

  • Marta Oliveira Unidade de Saúde Familiar Cardilium. Agrupamento Centros de Saúde do Médio Tejo. Administração Regional de Saúde de Lisboa e Vale do Tejo. Torres Novas.
  • Paulo Reis-Pina Casa de Saúde da Idanha. Sintra; Faculdade de Medicina da Universidade de Lisboa. Lisboa. https://orcid.org/0000-0002-4665-585X

DOI:

https://doi.org/10.20344/amp.19883

Keywords:

Cancer Pain, Neuralgia, Peripheral Nervous System Diseases/chemically induced, Quality of Life

Abstract

N/a.

Downloads

Download data is not yet available.

References

Capela A, Alonso R, Araújo A, Craveiro-Lopes B, Fragoso RM, Mansinho H, et al. A dor neuropática periférica induzida por quimioterapia no doente oncológico/sobrevivente de cancro. Acta Med Port. 2023;36:77-80.

Colvin LA. Chemotherapy-induced peripheral neuropathy (CIPN): where are we now? Pain. 2019;160:S1–10.

Pachman DR, Barton DL, Swetz KM, Loprinzi CL. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol. 2012;30:3687-96.

Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, et al. Incidence, prevalence and predictors of chemotherapy induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155:2461-70.

Tanay M, Armes J, Ream E. The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: a qualitative thematic synthesis. Eur J Cancer Care. 2017;26:e12443.

Published

2023-06-01

How to Cite

1.
Oliveira M, Reis-Pina P. Chemotherapy-Induced Peripheral Neuropathic Pain and the Impact on the Quality of Life. Acta Med Port [Internet]. 2023 Jun. 1 [cited 2024 Jun. 21];36(6):440-. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/19883

Issue

Section

Letters to the Editor